RHEUMATRACE
LIVE

Serial Number

79392510

Owner

Nordic Bioscience A/S

Attorney

Bradley M. Stohry

Filing Date

Sep 19, 2023

Add to watchlist:

No watchlists yet
View on USPTO

RHEUMATRACE Trademark

Serial Number: 79392510 • Registration: 8131504

RHEUMATRACE is a trademark filed by Nordic Bioscience A/S on September 19, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Nordic Bioscience A/S (10 trademarks)

Herlev Hovedgade 205-207

Entity Type: 99

Trademark Details

Filing Date

September 19, 2023

Registration Date

February 10, 2026

Published for Opposition

December 23, 2025

Goods & Services

Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; medical and scientific research, namely, identifying patients for clinical trials most likely to respond to a given treatment using biomarkers; development services in the field of diagnostic preparations, equipment and tests; advice, information and assistance relating to the foregoing

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 10, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 10, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 1, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 13, 2025 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 12, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 27, 2025 OPNR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Jun 12, 2025 GNS1
SUBSEQUENT FINAL EMAILED
Jun 12, 2025 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Jun 12, 2025 CFRC
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
May 28, 2025 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Feb 28, 2025 LIMG
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 20, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 13, 2025 GNFN
FINAL REFUSAL E-MAILED
Jan 13, 2025 GNFR
FINAL REFUSAL WRITTEN
Jan 13, 2025 CNFR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 26, 2024 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 26, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 26, 2024 TROA
REFUSAL PROCESSED BY IB
Jul 15, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 27, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jun 27, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 14, 2024 RFCR
NON-FINAL ACTION WRITTEN
May 31, 2024 CNRT
ASSIGNED TO EXAMINER
May 13, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 5, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 28, 2024 REPR